Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene/conjugated estrogens study for endometrial safety and osteoporosis prevention in postmenopausal women
2008-003203-32Phase 3Completed
- Sponsor
- Wyeth
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bazedoxifene and conjugated estrogens in menopause and osteoporosis (5 arms), sponsored by Wyeth. Primary endpoint: Incidence of endometrial hyperplasia at year 1. Started Jan 2009; status: completed.
02
Drugs
bazedoxifeneconjugated estrogens
03
Conditions
menopauseosteoporosis
Beyond the preview
Go deeper on 2008-003203-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003203-32.